Cortina Asset Management’s Standard BioTools LAB Stock Holding History

Cortina Asset Management’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-336,619	Closed	-$12.9M	–	269
2013 Q4	$12.9M	Sell	336,619 -8,636	-3%	-$254K	0.47%	78
2013 Q3	$7.58M	Sell	345,255 -181,623	-34%	-$3.57M	0.3%	121
2013 Q2	$9.2M	Buy	+526,878	New	+$9.25M	0.37%	104

Other funds holding LAB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cortina Asset Management's LAB Position: Q1 2014 in Review

Cortina Asset Management sold out of Standard BioTools (LAB) in Q1 2014, closing a stake of 336,619 shares — an estimated $12.9M sold.

Cortina Asset Management first reported a position in LAB in Q2 2013 and held it in 3 quarters. The position peaked at $12.9M in Q4 2013. 107 funds tracked by Wall St. Rank hold LAB as of Q1 2014.

Cortina Asset Management reported no remaining Standard BioTools position as of Q1 2014 after selling out during the quarter.
Cortina Asset Management sold 336,619 Standard BioTools shares in Q1 2014, an estimated $12.9M.
Cortina Asset Management first reported a position in Standard BioTools in Q2 2013 and held it in 3 quarters.
Cortina Asset Management's Standard BioTools position peaked at $12.9M in Q4 2013.
107 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2014.

Based on Cortina Asset Management's 13F filing for Q1 2014, filed 13 May 2014.